[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100194055":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":18,"centralContacts":22,"locations":32,"responsibleParty":79,"collaborators":81,"id":86,"slug":87,"hasResults":88,"nctId":89,"briefTitle":90,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":88,"sex":93,"minAge":94,"maxAge":10,"enrollmentInfo":95,"targetDuration":98,"studyType":99,"phases":10,"briefSummary":100,"conditions":101,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"The Rogosin Institute","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"Native, Renal Tissue Preservation Group",null,"Subjects who have a renal biopsy and the tissue is possessed and maintained by the RENAL AID repository.",{"label":13,"type":10,"description":14,"interventionNames":10},"Native, Non-tissue Preservation Group","1. Subjects who have had a renal biopsy but the tissue is not held by RENAL AID repository; and\u002For\n2. Subjects with diabetes and renal disease who have not had a renal biopsy.",{"label":16,"type":10,"description":17,"interventionNames":10},"Transplant Nephropathy Group","Subjects who have had a renal transplant and require a transplant biopsy for either surveillance or \"for-cause\" indications.",[19],{"name":20,"affiliation":5,"role":21},"Alan S Perlman, M.D.","PRINCIPAL_INVESTIGATOR",[23,28],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Nelson Chen, M.A.","CONTACT","646-317-0785","nec9039@nyp.org",{"name":29,"role":25,"phone":30,"phoneExt":10,"email":31},"Alan Perlman, M.D.","212-746-1580","alp9021@nyp.org",[33],{"facility":5,"status":34,"city":35,"state":35,"zip":36,"country":37,"countryCode":38,"cosmosGeoPoint":39,"geoPoint":44,"contacts":45},"RECRUITING","New York","10021","United States","US",{"type":40,"coordinates":41},"Point",[42,43],-74.00597,40.71427,{"lat":43,"lon":42},[46,50,52,55,57,59,61,63,65,67,69,71,73,75,77],{"name":47,"role":25,"phone":48,"phoneExt":10,"email":49},"Betty-Jane Sloan, M.A.","646-317-0701","bjsloan@nyp.org",{"name":51,"role":21,"phone":10,"phoneExt":10,"email":10},"Alan S Perlman, MD",{"name":53,"role":54,"phone":10,"phoneExt":10,"email":10},"Nathaniel Berman, MD","SUB_INVESTIGATOR",{"name":56,"role":54,"phone":10,"phoneExt":10,"email":10},"James M Chevalier, MD",{"name":58,"role":54,"phone":10,"phoneExt":10,"email":10},"Choli Hartono, MD",{"name":60,"role":54,"phone":10,"phoneExt":10,"email":10},"Surya V Seshan, MD",{"name":62,"role":54,"phone":10,"phoneExt":10,"email":10},"Manikkam Suthanthiran, MD",{"name":64,"role":54,"phone":10,"phoneExt":10,"email":10},"John CL Wang, MD",{"name":66,"role":54,"phone":10,"phoneExt":10,"email":10},"Thomas S Parker, PhD",{"name":68,"role":54,"phone":10,"phoneExt":10,"email":10},"Daniel M Levine, PhD",{"name":70,"role":54,"phone":10,"phoneExt":10,"email":10},"David Serur, MD",{"name":72,"role":54,"phone":10,"phoneExt":10,"email":10},"Jun Lee, MD",{"name":74,"role":54,"phone":10,"phoneExt":10,"email":10},"Liu M Frank, MD",{"name":76,"role":54,"phone":10,"phoneExt":10,"email":10},"Meredith J Aull, PharmD",{"name":78,"role":54,"phone":10,"phoneExt":10,"email":10},"Nelson Chen, CRC",{"type":80,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[82,84],{"name":83,"class":6},"New York Presbyterian Hospital",{"name":85,"class":6},"Weill Medical College of Cornell University","100194055","repository-of-novel-analytes-leading-to-autoimmune-inflammatory-and-diabetic-nephropathies-renal-aid-100194055",false,"NCT01802034","Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)","RENAL AID","Key Inclusion Criteria:\n\nAll Groups:\n\n* Males or females\n* 18 years of age and older\n* Willing and able to provide informed consent\n\nNative Biopsy Tissue Group:\n\n\\- Require an initial kidney biopsy for medical necessity\n\nNative Kidney, Non-tissue Group:\n\n* Previously had a kidney biopsy and the tissue is not stored in this biorepository; or\n* Have diabetes and kidney disease and have not had a kidney biopsy\n\nAllograft Tissue Group:\n\n\\- Have undergone a renal transplant and require a transplant biopsy for either surveillance or \"for-cause\" indications.\n\nKey Exclusion Criteria for all Groups:\n\n\\- Inability to provide informed consent.","ALL","18 Years",{"count":96,"type":97},2000,"ESTIMATED","10 Years","OBSERVATIONAL","A central goal of this data repository is to collect data from a large population of subjects with a variety of renal disease states. Cohorts will include subjects with diabetes, inflammatory\u002Fautoimmune and transplant related renal conditions. Additionally, the repository will have the capacity to store biospecimens and electronic data in control subjects without established renal disease. This initiative will provide an opportunity to compare data from various disease states and controls with the objective of determining clinical and biological factors that predict disease progression, response to therapy and identify discriminating noninvasive clinical and biological features that predict renal biopsy findings.",[102,103,104,105,106],"Kidney Diseases","Kidney Failure, Chronic","Diabetic Nephropathy","Lupus Nephritis","Glomerulonephritis, IGA","2025-04-01",{"date":109,"type":110},"2025-04-04","ACTUAL",{"date":112,"type":10},"2013-02",{"date":114,"type":97},"2028-08",{"name":5,"class":6},1]